Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Online mortgage calculator UK.
Popular Articles
Natural Remedies

Matthew Lehman Of SPRI Clinical Trials Speaks On Designing Trials For Success At The Trout Group Investor Relations Seminar
In designing and conducting clinical trials, it is critical to meet FDA objectives while preventing program "drift," according to Matthew Lehman, chief operating officer of SPRI Clinical Trials-Global, LLC in his remarks at a recent seminar for biotechnology companies.
generic viagra online
What Are Condoms? How To Use a Condom
There are two types of condoms; male and female. A condom is a barrier contraceptive - it blocks the route a sperm would take to fertilize an egg. They can be made from latex rubber, polyurethane, or lambskin. According the NHS (National Health Service, UK), males condoms are 98% effective against pregnancy if used correctly, while female condoms are about 95% effective. Nobody is sure what the origin of the English word "condom" is. There were rumors that Dr. Condom invented the condom for King Charles II of England. However, it is most likely that Dr. Condom, otherwise known as The Earl of Condom, never existed - also, condoms were around long before that period. Most likely the name comes from the Italian word guantone, which comes from the Italian word guanto, meaning "glove".
News of the day
Swedish University President Awarded Prestigious Distinction
Karolinska Institutet accounts for almost half of the academic medical research conducted in Sweden, and contributes regularly to new discoveries that save lives and alleviate suffering. Today, the university"s president, Harriet Wallberg-Henriksson, is to receive an honorary distinction for eminent women in science by Exploratorium, the renowned American science museum.
Cardiovascular

Retroperitoneal Lymph Node Dissection In Patients With High Risk Testicular Cancer

UroToday.com - We performed a retrospective review of retroperitoneal lymph node dissection (RPLND) patients with high risk features (>30% embryonal carcinoma, with or without lymphovascular invasion) and compared primary (P-RPLND) versus post-chemotherapy (PC-RPLND) patients. The average percent embryonal carcinoma between P-RPLND vs. PC-RPLND was 75.3 vs. 71.2%, respectively. The average LVI between P-RPLND vs. PC-RPLND was 53.4 vs. 61.4%, respectively. Regarding pathologic stage II (PS II) disease, there were 37 (49%) and 35 (61%) cases, respectively. Only 2 (3%) of patients who underwent P-RPLND were noted to have systemic disease outside the retroperitoneum (metastasis to the lung and mesentery each). Overall, there were 6 (8%) and 5 (9%) recurrences between the P-RPLND and PC-RPLND groups all within 2 years of surgery. P-RPLND offered less blood loss, shorter operative time and fewer complications than PC-RPLND. Our findings highlight that P-RPLND can spare a majority of these high risk patients the potential long-term toxicity of chemotherapy compounded by radiation exposure from surveillance imaging. Written by Stephen Williams, MD as part of Beyond the Abstract on UroToday.com UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com Copyright © 2009 - UroToday


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009